Your browser doesn't support javascript.
loading
Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.
Ozyerli-Goknar, Ezgi; Kala, Ezgi Yagmur; Aksu, Ali Cenk; Bulut, Ipek; Cingöz, Ahmet; Nizamuddin, Sheikh; Biniossek, Martin; Seker-Polat, Fidan; Morova, Tunc; Aztekin, Can; Kung, Sonia H Y; Syed, Hamzah; Tuncbag, Nurcan; Gönen, Mehmet; Philpott, Martin; Cribbs, Adam P; Acilan, Ceyda; Lack, Nathan A; Onder, Tamer T; Timmers, H T Marc; Bagci-Onder, Tugba.
Afiliación
  • Ozyerli-Goknar E; Koç University Research Center for Translational Medicine (KUTTAM), Rumelifeneri Yolu, Sariyer, Istanbul, 34450, Türkiye.
  • Kala EY; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK) Partner Site Freiburg, Heidelberg, Germany.
  • Aksu AC; Department of Urology, Medical Center-University of Freiburg, Freiburg, Germany.
  • Bulut I; Koç University Research Center for Translational Medicine (KUTTAM), Rumelifeneri Yolu, Sariyer, Istanbul, 34450, Türkiye.
  • Cingöz A; Koç University Research Center for Translational Medicine (KUTTAM), Rumelifeneri Yolu, Sariyer, Istanbul, 34450, Türkiye.
  • Nizamuddin S; Koç University Research Center for Translational Medicine (KUTTAM), Rumelifeneri Yolu, Sariyer, Istanbul, 34450, Türkiye.
  • Biniossek M; Koç University Research Center for Translational Medicine (KUTTAM), Rumelifeneri Yolu, Sariyer, Istanbul, 34450, Türkiye.
  • Seker-Polat F; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK) Partner Site Freiburg, Heidelberg, Germany.
  • Morova T; Department of Urology, Medical Center-University of Freiburg, Freiburg, Germany.
  • Aztekin C; Institute for Molecular Medicine and Cell Research, University of Freiburg, Freiburg, Germany.
  • Kung SHY; Koç University Research Center for Translational Medicine (KUTTAM), Rumelifeneri Yolu, Sariyer, Istanbul, 34450, Türkiye.
  • Syed H; Koç University School of Medicine, Istanbul, Türkiye.
  • Tuncbag N; Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
  • Gönen M; Koç University School of Medicine, Istanbul, Türkiye.
  • Philpott M; Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
  • Cribbs AP; Koç University Research Center for Translational Medicine (KUTTAM), Rumelifeneri Yolu, Sariyer, Istanbul, 34450, Türkiye.
  • Acilan C; Koç University School of Medicine, Istanbul, Türkiye.
  • Lack NA; Biostatistics, Bioinformatics and Data Management Lab, KUTTAM, Istanbul, Türkiye.
  • Onder TT; Koç University Research Center for Translational Medicine (KUTTAM), Rumelifeneri Yolu, Sariyer, Istanbul, 34450, Türkiye.
  • Timmers HTM; Koç University School of Medicine, Istanbul, Türkiye.
  • Bagci-Onder T; Department of Chemical and Biological Engineering, Koç University, Istanbul, Türkiye.
Cell Commun Signal ; 21(1): 328, 2023 11 16.
Article en En | MEDLINE | ID: mdl-37974198
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Nucleares / Glioblastoma Límite: Humans Idioma: En Revista: Cell Commun Signal Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Nucleares / Glioblastoma Límite: Humans Idioma: En Revista: Cell Commun Signal Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido